Form D · Biotechnology
FERROKIN BIOSCIENCES INC
San Carlos, CA · CIK 0001449185
Offering snapshot reported Feb 17, 2012 · SEC filing
- Reported sold
- $3M Offering amount: $6M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Feb 10, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 17, 2012 | Initial | $3,000,000 | No comparison | 6 | SEC filing |
| Jun 16, 2010 | Initial | $5,999,997 | No comparison | 6 | SEC filing |
| Nov 16, 2009 | Amendment | $15,000,000 | No comparison | 4 | SEC filing |
| Oct 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-173622
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| n/a | None |
Source: Form D, filed Feb 17, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bryant E. Fong | Director |
| Dennis Henner, Ph.D. | Director |
| Hugh Y. Rienhoff, Jr. | Director, Executive |
| Hugh Y. Rienhoff, Jr., M.D. | Director, Executive |
| Marten Steen | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2729 Debbie Court
San Carlos, CA, 94070
San Carlos, CA, 94070